CM
CMD

Castleark Management’s Cantel Medical Corporation CMD Stock Holding History

Castleark Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-36,254
Closed -$2.85M – 423
2016
Q4 		$2.85M Sell
36,254
-92,600
-72% -$7.2M 0.09% 241
2016
Q3 		$10M Sell
128,854
-9,145
-7% -$663K 0.3% 94
2016
Q2 		$9.48M Buy
137,999
+6,900
+5% +$476K 0.3% 91
2016
Q1 		$9.36M Buy
131,099
+7,730
+6% +$485K 0.29% 87
2015
Q4 		$7.67M Buy
123,369
+53,560
+77% +$3.27M 0.23% 113
2015
Q3 		$3.96M Buy
+69,809
New +$3.7M 0.13% 192

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Castleark Management's CMD Position: Q1 2017 in Review

Castleark Management sold out of Cantel Medical Corporation (CMD) in Q1 2017, closing a stake of 36,254 shares — an estimated $2.85M sold.

Castleark Management first reported a position in CMD in Q3 2015 and held it in 6 quarters. The position peaked at $10M in Q3 2016. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2017.

  • Castleark Management reported no remaining Cantel Medical Corporation position as of Q1 2017 after selling out during the quarter.
  • Castleark Management sold 36,254 Cantel Medical Corporation shares in Q1 2017, an estimated $2.85M.
  • Castleark Management first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 6 quarters.
  • Castleark Management's Cantel Medical Corporation position peaked at $10M in Q3 2016.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2017.

Based on Castleark Management's 13F filing for Q1 2017, filed 15 May 2017.